Skip to content

Camarin E. Rolle

3 papers in the library · 1 citation · publishing 2019-2025

Papers

Sort Most recent Most cited

Is ibogaine treatment durable? 12-month follow-up of magnesium–ibogaine therapy (MISTIC) in Special Operations Veterans with traumatic brain injuries

Research Square December 17, 2025 Camarin E. Rolle, Nolan Williams, Afik Faerman et al.

Abstract Traumatic brain injury (TBI) can result in chronic functional disability and is associated with persistent psychiatric symptoms, including posttraumatic stress disorder (PTSD), depression, and anxiety. Ibogaine, an oneirogenic alkaloid with unique pharmacological properties, has shown initial promise as a potential treatment for TBI-related sequelae. We previously observed large...

Mystical experiences during magnesium-Ibogaine are associated with improvements in PTSD symptoms in veterans.

Journal of Affective Disorders November 18, 2025 Randi Brown, Jennifer I. Lissemore, Kenneth Shinozuka et al. 1 citation

Ibogaine is an atypical psychedelic that evokes unique subjective effects, including mystical experiences. Mystical experiences have shown a mediating effect on clinical improvements following treatment with several psychedelic substances; however, the relationship between mystical experiences and clinical outcomes following ibogaine remains unclear. We examined the association between mystical...

Closed-loop Digital Meditation Improves Sustained Attention in Young Adults

Nature Human Behaviour June 3, 2019 David A Ziegler, Alexander J. Simon, Courtney L. Gallen et al.

Attention is a fundamental cognitive process that is critical for essentially all aspects of higher-order cognition and real-world activities. Younger generations have deeply embraced information technology and multitasking in their personal lives, school and the workplace, creating myriad challenges to their attention. While improving sustained attention in healthy young adults would be...